GeoVax Labs (GOVX) Preferred Shares (2012 - 2021)
GeoVax Labs (GOVX) posted quarterly Preferred Shares of $76095.0 for Q1 2021, down 79.77% year-over-year from $376095.0 in Q1 2020, and little changed quarter-over-quarter from $76095.0 in Q4 2020.
GeoVax Labs (GOVX) Preferred Shares (2012 - 2021) Analysis & Trends
GeoVax Labs (GOVX) has reported Preferred Shares for 10 consecutive years, with $76095.0 the latest figure, recorded in Q1 2021.
- In Q1 2021, Preferred Shares fell 79.77% year-over-year to $76095.0; the TTM figure through Mar 2021 stood at $76095.0 (down 79.77% YoY), while the FY2020 annual figure was $76095.0, down 96.06% from the prior year.
- Preferred Shares held at $76095.0 in Q1 2021 per GOVX's latest filing, from $76095.0 in the prior quarter.
- Across five years, Preferred Shares topped out at $2.3 million in Q2 2019 and bottomed at $76095.0 in Q3 2020.
- Historically, Preferred Shares has averaged $1.1 million across 5 years, with a median of $980000.0 in 2017.
- Annual changes were most pronounced in 2019 — Preferred Shares soared 177.33% — and 2020, when it tumbled 96.72%.
- GeoVax Labs' Preferred Shares stood at $980000.0 in 2017, then surged by 101.16% to $2.0 million in 2018, then declined by 1.97% to $1.9 million in 2019, then sank by 96.06% to $76095.0 in 2020, then changed by 0.0% to $76095.0 in 2021.
- Business Quant data shows GOVX's Preferred Shares at $76095.0 in Q1 2021, $76095.0 in Q4 2020, and $76095.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GeoVax Labs | 2.88 Mn | -260,493.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 76,095.00 |
| Dec 31, 2020 | 76,095.00 |
| Sep 30, 2020 | 76,095.00 |
| Jun 30, 2020 | 376,095.00 |
| Mar 31, 2020 | 376,095.00 |
| Dec 31, 2019 | 1.93 Mn |
| Sep 30, 2019 | 2.32 Mn |
| Jun 30, 2019 | 2.34 Mn |
| Mar 31, 2019 | 1.59 Mn |
| Dec 31, 2018 | 1.97 Mn |
| Sep 30, 2018 | 1.19 Mn |
| Jun 30, 2018 | 842,990.00 |
| Mar 31, 2018 | 842,990.00 |
| Dec 31, 2017 | 980,000.00 |
| Sep 30, 2017 | 980,000.00 |
| Jun 30, 2017 | 980,000.00 |
| Mar 31, 2017 | 940,705.00 |
| Dec 31, 2016 | 940,705.00 |
| Sep 30, 2016 | 940,705.00 |
| Jun 30, 2016 | 940,705.00 |